Canada
HTuO Biosciences, founded in 2020, is a cutting-edge player in the Biotechnology and Pharmaceutical industries, headquartered in Canada. With its slogan, "HTuO Biosciences is a drug discovery company that works at the interface of physics, chemistry, & computer programming," the company emphasizes its unique interdisciplinary approach to drug discovery.
The core of HTuO Biosciences lies in its proprietary advanced molecular simulation technology. By integrating principles of chemistry, physics, and computer programming, the startup is positioned to revolutionize the way we predict molecular behavior with increased accuracy—a critical factor for the progress of drug discovery processes.
In terms of financial traction, the company secured a Seed Round investment on 01 January 2022 with participation from the Archangel Network of Funds and York Angels Investors. This strategic investment reflects confidence in their innovative solution and growth potential.
